Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Polymorphic regulation of mitochondrial fission and fusion modifies phenotypes of microglia in neuroinflammation

Abstract

Microglia are the resident macrophages of the central nervous system and play complex roles in the milieu of diseases including the primary diseases of myelin. Although mitochondria are critical for cellular functions and survival in the nervous system, alterations in and the roles of mitochondrial dynamics and associated signaling in microglia are still poorly understood. In the present study, by combining immunohistochemistry and 3D ultrastructural analyses, we show that mitochondrial fission/fusion in reactive microglia is differentially regulated from that in monocyte-derived macrophages and the ramified microglia of normal white matter in myelin disease models. Mouse cerebral microglia in vitro demonstrated that stimulation of TLR4 with lipopolysaccharide, widely used to examine microglial reactions, caused the activation of the mitochondrial fission protein, dynamin-related protein 1 (Drp1) and enhanced production of reactive oxygen species (ROS). The increase in the ROS level activated 5′ adenosine monophosphate-activated protein kinase (AMPK), and facilitated elongation of mitochondria along the microtubule tracks. These results suggest that the polymorphic regulation of mitochondrial fission and fusion in reactive microglia is mediated by distinct signaling under inflammatory conditions, and modulates microglial phenotypes through the production of ROS.

Introduction

Microglia are specialized macrophages that reside in the central nervous system (CNS) and have distinct origins, morphologies and functions from other glial cells in the nervous system and macrophages in other organs1, 2. The morphological reactions of microglia are prominent in neurological disorders including the primary diseases of myelin. Furthermore, the morphology and gene expression of reactive microglia can be distinct from those of macrophages derived from infiltrating monocytes in neuroinflammation3,4,5. Microglial reactions are triggered by diverse stimuli and, most importantly, by neuronal injury or altered activity as well as exposure to plasma proteins after blood-brain barrier dysfunctions6. The activation of microglia has been classified into two phenotypes, pro-inflammatory (M1) and anti-inflammatory (M2), by analogies to peripheral macrophages; however, this classification is no longer regarded as accurate or useful4. Although dynamic changes in microglial functions may contribute to the phenotypes of various neurological disorders7, the regulatory mechanisms responsible for and associated changes in organelles underlying the complexity of microglial reactions are only beginning to be elucidated.

Mitochondria are critical for cellular metabolism and death, and their functions are controlled by their dynamics including fission/fusion8,9,10. Mitochondrial fission/fusion are regulated by molecules such as Dynamin-related protein 1 (Drp1) and Mitofusin (Mfn) 1/211,12,13 and are mediated by other cellular components such as the cytoskeleton14, 15. Mitochondrial fission/fusion are also associated with the generation of reactive oxygen species (ROS). The role of ROS signaling has been demonstrated in a bewildering number of cellular events including damage to cell components. The production of ROS is also essential for host defenses in the periphery16,17,18. Therefore, mitochondrial fission/fusion and associated signaling involving ROS need to be investigated in microglia, due to their unique roles in brain physiology.

In the present study, the mitochondrial morphology of reactive microglia in vivo was examined and compared with those of monocyte-derived macrophages and microglia remote from tissue pathology, in myelin disease models. In order to model temporal alterations in mitochondrial fission/fusion in reactive microglia, we used primary microglial cultures and stimulation of Toll-like receptor 4 (TLR4) with lipopolysaccharide (LPS), which were widely used to study inflammatory reactions of microglia leading to injuries of neurons and oligodendrocytes6, 19, 20. The results suggest that microglial reactions induce dynamic mitochondrial fission/fusion which are associated with distinct signaling pathways. Alteration in mitochondrial dynamics may contribute to the differential functions of reactive microglia in neurological diseases.

Results

Mitochondrial dynamics of reactive microglia in demyelinating disease models in vivo

Using Ccr2 rfp/+::Cx3cr1 gfp/+ mice21, 22, which tissue-resident microglia-derived macrophages (MiDM) and infiltrating monocyte-derived macrophages (MDM) were labeled with GFP and RFP, respectively, the morphological characteristics of MiDM and MDM in the spinal cord at the onset of experimental autoimmune encephalomyelitis (EAE) were examined by immunostaining for RFP or GFP and observations with SBF-SEM (Fig. 1a). DAB-precipitation derived from GFP (MiDM) or RFP (MDM) immunostaining near the tissue surface facilitated the observation of organelles within the two populations of DAB-positive cells (Fig. 1b,c). In these analyses, the nuclei of GFP-positive MiDM (Fig. 1c) appeared to be more spherical compared with RFP-positive MDM (Fig. 1b). When nuclei were classified into 4 categories, 98% of cells with round nuclei were GFP+MiDM, while 95% of cells with irregular nuclei were RFP+MDM (Fig. 1d–f). MDM with complex nuclei had rounder and shorter mitochondria (Fig. 1g,k,i), whereas MiDM with round nuclei had longer mitochondria (Fig. 1h,l,j). Mitochondrial lengths were longer in MiDM than in MDM (Fig. 1m), while no significant differences were observed in mitochondrial volumes (Fig. 1n). These results suggest that MiDM have longer and thinner mitochondria and spherical nuclei than MDM in spinal cord tissues at the onset of EAE.

Figure 1
figure 1

Longer mitochondria and round nuclei of microglia-derived macrophages in spinal cord tissues at the onset of experimental autoimmune encephalomyelitis. (a) After fixation and slicing (i), brain tissues were immunostained with DAB (ii), and embedded in resins (a, iii). Serial images were acquired for 3D reconstruction (a, iv). Reconstruction of nuclei (upper panels) and original immunoelectron microscopic images (middle, lower panels) of RFP- (b, red) and GFP- (c, green) positive cells in the spinal cord of a Ccr2 rfp/+::Cx3cr1 gfp/+ mouse with DAB deposits (b,c, asterisks). The nuclei of DAB negative cells (center) and immunocontrols (right) are also shown. The grading (d) and counting (e,f) of nuclear shapes in the RFP-positive monocyte-derived macrophages (MDM) and GFP-positive microglia-derived macrophages (MiDM). Single images (g,h) and nuclear (i,j) and mitochondrial (k,l) 3D reconstructions of MDM (g,k,i, red) and MiDM (h,j,l, green) are shown. Mitochondria are indicated (g,h, arrowheads). Long and short mitochondria are colored in blue and magenta, respectively (k,l). The mitochondrial length (m) and volume (n) of MiDM and MDM are compared. ns: not significant. ***p < 0.001 in the U-test. N = 648 or 786 for mitochondria in MDM or MiDM. Bars: 2 μm.

The differential fission/fusion of mitochondria may be related to the activation of macrophage lineage cells18. In order to address this possibility in vivo, mitochondrial morphologies were examined in a mouse model of Pelizaeus-Merzbacher disease (PMD), a congenital myelin disorder linked to the proteolipid protein (PLP) gene23, 24. In the mouse model expressing extra copies of PLP, progressive myelin loss and an increased number of macrophages were observed in the CNS, with most macrophages (>90%) being derived from resident microglia25, 26. Cells with DAB-deposits of ionized calcium-binding adapter molecule 1 (Iba1), a member of EF hand proteins which is expressed in the microglia of CNS as well as peripheral macrophages, were observed near the surface of the tissues (Figs 1a, 2a–h). In myelinated white matter from wild-type mice, Iba1-positive microglia had round-oval nuclei and extended thin processes containing long mitochondria (Fig. 2i,k,m). In contrast, in the demyelinated white matter of mutant mice, Iba1-positive amoeboid microglia with round-oval nuclei had greater numbers of small and short mitochondria than the ramified microglia in wild-type mice (Fig. 2j,l,n). The median length and volume of mitochondria was 2–3-fold longer and larger in ramified microglia compared with the amoeboid microglia (Fig. 2o,p). These results suggest that reactive microglia are characterized more by a constant nuclear morphology and mitochondrial fragmentation than ramified microglia in vivo.

Figure 2
figure 2

Shorter and smaller mitochondria predominate in amoeboidal microglia in demyelinated cerebellar white matter obtained from mice overexpressing proteolipid protein (PLP). Light micrographs of Iba1 immunostaining in the cerebella of 5-month-old wild-type (WT, a,b) and PLP-overexpressing (PLPtg, c–f) mice. Immunocontrol sections are also shown (e,f). In immunoelectron micrographs (EM) with DAB deposits for Iba1 (g,h, arrows), the area indicated with a rectangle (g) is magnified (h). Single electron micrographs (i,j) and 3D reconstructions of nuclei (k,l) and mitochondria (m,n) of Iba1-positive cells in the cerebellar white matter of WT (i,k,m) and PLPtg (j,l,n) mice are shown and mitochondrial length (o) and volume (p) were statistically compared. Long and short mitochondria are colored in blue and magenta, respectively (m,n). ***p < 0.001 in the U-test. N = 68 or 506 for mitochondria in WT or PLPtg microglia. Bars: 50 μm (a,c,e), 20 μm (b,d,f), 2.5 μm (g–j).

Transient fragmentation and subsequent elongation of mitochondria in reactive microglia stimulated with LPS in vitro

In order to elucidate mitochondria alterations and associated signaling pathways during microglial reactions, primary cultures of microglia were utilized and subjected to 1 μg/mL LPS, which cause inflammatory reactions of microglia by signaling to TLR4 (Fig. 3a)6, 19, 20, 27. Immunostaining for Iba1 showed that the circularity of the cytoplasm (proportional to the cellular area/perimeter2) was greater in cultures 2, 6 and 12 hr after the stimulation than in unstimulated control cultures (Fig. 3b,e), indicating that the LPS stimulation induces the amoeboid morphology. Immunostaining was used to elucidate the mitochondrial outer membranes (TOM20; Fig. 3c, VDAC1; data not shown) and inner membranes (COX I; Fig. 3d, COX Va; data not shown). Mitochondrial length was shortened 2 hr after the stimulation (Fig. 3f,g). Mitochondria were longer 6 and 12 hr after the stimulation than 2 hr after the stimulation (Fig. 3f,g). SBF-SEM observation and the reconstruction of mitochondria identified by the typical cristae morphology (Fig. 4a,b) showed that the lengths and numbers of branches were significantly shorter and fewer, respectively, 2 hr after the LPS stimulation (Fig. 4c–f), and returned to control levels 12 hr after the stimulation (Fig. 4e,f). We speculated that the elongation of mitochondria was dependent on microtubules, because double immunostaining for α-tubulin and COX I showed that elongated mitochondria co-localized with microtubules (Fig. 5a–c). This hypothesis was confirmed by nocodazole, an inhibitor of microtubule polymerization, impairing the elongation of mitochondria (Fig. 5d). These results demonstrate that the activation of microglia by LPS induced transient and reversible shortening and the subsequent elongation and network restoration of mitochondria in vitro.

Figure 3
figure 3

A lipopolysaccharide (LPS) stimulation induces fragmentation and the subsequent elongation of mitochondria in primary microglial cultures. (a) Primary cultures of microglia were incubated with or without LPS for 2, 6 and 12 hr and then immunocytochemically stained (ICC) for markers of microglia (Iba1), the outer mitochondrial membrane (OMM and TOM20), and inner mitochondrial membrane (IMM and COX I). Representative images of immunofluorescence for Iba1 (b1-4), TOM20 (c1-4), and COX I (d1-4), the circularity (proportional to cellular area/perimeter2) (e), and mitochondrial length measured as the length of TOM20- (c, arrows, f) and COX I-positive (d, arrows, g) profiles are shown. Cont: unstimulated cultures. ****p < 0.0001 in the U-test. N (Cont, 2 hr, 6 hr, 12 hr) = (130, 120, 128, 113) cells in (e), (2538, 3626, 3162, 2259) mitochondria in (f), and (1135, 1704, 1280, 1348) mitochondria in (g). Medians (bars) and quartile ranges (boxes) are shown (e–g). Bars: 50 μm (b), 20 μm (c,d).

Figure 4
figure 4

Electron microscopic 3D reconstructions showing mitochondrial fragmentation and subsequent elongation with network restoration in cultured microglia after a stimulation with lipopolysaccharide (LPS). Cultured microglia with or without the LPS stimulation (a, i) were fixed and embedded in resins to image with SBF-SEM (a, ii) and mitochondria were reconstructed from the serial images (a, iii). Mitochondria with typical cristae (b, yellow) were reconstructed and colored (c,d) in cultured microglia not stimulated with LPS (Control, c) and 2 hr after the LPS stimulation (d, LPS 2hr). Measurements of length (e) and branch number (f) are shown. Long and short mitochondria are colored in blue and pink, respectively (c,d). ***p < 0.001 in the U-test. Bars: 5 μm.

Figure 5
figure 5

Mitochondrial elongation along microtubules following the stimulation with lipopolysaccharide (LPS). An experimental scheme shows that primary microglial cultures were quickly frozen (QF), freeze-substituted (FS), and immunostained for α-tubulin and the inner mitochondrial membrane (IMM) marker, COX I (a). Double immunostaining for mitochondria (COX I) and microtubules (α-tubulin) in microglia without the LPS stimulation (b, arrows) or 12 hr after the LPS stimulation (c, arrows). Areas indicated with rectangles (b3, c3, d3) are shown in the insets. Fluorescence intensity was measured along the lines (b3, c3, d3), and the arrows show the strong fluorescence intensities of α-tubulin (magenta) and COX I (green) at the same locations (b4, c4). Bars: 30 μm.

Drp1 activation and mitochondrial ROS production mediating LPS-induced mitochondrial fragmentation

Since the activation of Drp1 controls mitochondrial fission28, we examined Ser616 phosphorylation, which activates Drp1 after the LPS stimulation (Fig. 6a). Western blotting analyses revealed that the phosphorylation of Ser616 increased 2–6 hr after the stimulation, and returned to control levels 12 hr after the stimulation (Fig. 6b). The treatment with 50 μM Mdivi-1, a Drp1 inhibitor (Fig. 6a), diminished mitochondrial shortening (Fig. 6c–e)29. Drp1 activation and mitochondrial fission have been shown to promote the generation of ROS30. In order to examine alterations in and the roles of ROS production after the LPS stimulation, mitochondrial ROS (mtROS) was measured with MitoSOX, a mitochondrial superoxide indicator (Fig. 6a). The fluorescence intensity of MitoSOX increased 2hr after the LPS stimulation (Fig. 6f,g,j) and returned to the basal levels 6–12 hr after the stimulation (Fig. 6h,i,j). The treatment with Mdivi-1 abolished the increase in MitoSOX fluorescence intensity observed 2hr after the LPS stimulation (Fig. 6a,k–m). The generated ROS appeared to contribute mitochondrial fragmentation 2hr after the LPS stimulation, since treatment with 1 mM N-acetyl cysteine (NAC), a ROS scavenger, diminished the mitochondrial fragmentation (Fig. 6n–r). Mitochondrial length after 12hr treatment with NAC was comparable to those with 12hr treatment with LPS and controls without LPS stimulation, but longer than that with 2hr treatment with LPS and NAC (Fig. 6n–r). Since IL-10 is a pivotal regulator in progression of EAE and the production of IL-10 is increased by LPS stimulation and promoted by post-translational modification of microtubules31,32,33, we examined secretion levels of IL-10 by enzyme-linked immunosorbent assay (ELISA). Although LPS stimulation increased production of IL-10, treatment with Mdivi-1 did not significantly affect the IL-10 production (Supplementary Fig. 1). These results suggest that mitochondrial fission via the activation of Drp1 is induced by the TLR4 stimulation and increases the mitochondrial production of ROS which contributes to mitochondrial fission.

Figure 6
figure 6

Lipopolysaccharide (LPS)-induced mitochondrial fragmentation in microglia is controlled by Drp1 signaling and evokes mitochondrial reactive oxygen species (ROS) generation. Primary microglial cultures were incubated without LPS (Cont) or with LPS for 2 (2hr), 6 (6hr) and 12 hr (12hr), and subjected to Western blotting analyses for total Drp1 and Drp1 activated by the phosphorylation at Ser616 (p-Drp1) or MitoSOX analyses to detect mitochondrial ROS (a). Primary microglial cultures were stimulated by LPS for 2 hr with or without an inhibitor for Drp1 (Mdivi-1) or N-acetyl cysteine (NAC) and subjected to immunostaining or MitoSOX analyses (a). Western blotting of phosphorylated Drp1 and total Drp1 following LPS stimulation. (b). Representative images (c,d) and measured lengths (e) of TOM20-immunopositive mitochondrial profiles are shown. N = 2672 (Cont), 5040 (Vehicle), and 2820 (Mdivi-1) mitochondria in (e). MitoSOX images of primary microglial cultures without the LPS stimulation (Cont, f) or with the LPS stimulation for 2 (2hr, g), 6 (6hr, h) or 12 (12hr, i) hr are shown and quantified (j). N = 287 (control), 444 (LPS 2hr), 318 (LPS 6hr) and 309 (LPS 12hr) cells. Each dot represents each cell. Representative images (k,l) and the mean fluorescence intensity (m) of MitoSOX in microglial cultures 2 hr after LPS stimulation with (l) or without (k) Mdivi-1 treatment. N = 336 (Cont), 306 (Vehicle) and N = 297 (Mdivi-1) cells. Representative images (n–p) and measured mitochondrial length (r) after 2hr (n,p) or 12hr (o,q) LPS stimulation of Toll-like receptor 4 (TLR4) with (p,q) or without (n,o) NAC treatment. N = 173 (Cont), 570 (2hr-Vehicle), 411 (12hr-Vehicle), 572 (2hr-NAC), and 364 (12hr-NAC) mitochondria in (r). ***p < 0.001, ****p < 0.0001 and n.s.: not significant in the U-test. Medians (e,j,m,p, bars) with quartile ranges (e,p, boxes; j,m, whiskers) are shown. Bars: 20 μm (c,d, n-q), 50 μm (f–i, k,l).

Mitochondrial elongation mediated by production of ROS and activation of AMPK

Increase in superoxide activate 5′ adenosine monophosphate-activated protein kinase (AMPK) and facilitate mitochondrial biogenesis34,35,36. When microglia were treated with 1 μM hydrogen peroxide (H2O2) for 2 or 12 hr (Fig. 7a), the phosphorylation of AMPK at Thr172, which activates AMPK, was induced (Fig. 7b). Incubation with H2O2 in the presence of 5 μM Compound C (Dorsomorphin), a selective AMPK inhibitor (Fig. 7a)37, decreased AMPK phosphorylation (Fig. 7b). Mitochondrial length was shorter 2 hr after the treatment with hydrogen peroxide, and returned to basal levels 12 hr after the stimulation (Fig. 7c,d,g). Mitochondrial elongation after the hydrogen peroxide treatment was inhibited by Compound C (Fig. 7e,f,g).

Figure 7
figure 7

ROS activates 5′ adenosine monophosphate-activated protein kinase (AMPK) to facilitate mitochondrial elongation. (a) Primary microglial cultures were treated for 2 or 12 hr with or without hydrogen peroxide (H2O2) and the selective AMPK inhibitor, Compound C (Comp C), and then subjected to Western blotting (WB) and immunostaining (ICC). Western blotting of AMPK phosphorylated at Thr172 (p-AMPK) with treatments of H2O2 and Comp C (b, left), and quantification of the Western blotting analyses (b, right) are shown. *p < 0.05 in the t-test (N = 6). Each dot represents each replicate and means (bars) are shown. Representative images (c–f) and the measured lengths (g) of TOM20-immunopositive mitochondrial profiles with treatments of H2O2 and Comp C. N = 1975 (control), 4536 (H2O2 2 hr), 3156 (H2O2 12 hr), 3486 (H2O2 2 hr + Comp C), and 2966 (H2O2 12hr + Comp C) for mitochondria. n.s.: not significant and ****p < 0.0001 in the U-test. Medians (g, bars) with quartile ranges (g, boxes) are shown. Bars: 20 μm.

In order to confirm the involvement of ROS and AMPK in mitochondrial fission/fusion after the LPS stimulation, microglial cultures were stimulated with LPS in the presence or absence of NAC, and Compound C (Fig. 8a). Western blotting analysis showed that stimulation by LPS for 12 hr induced phosphorylation of AMPK at Thr172 (Fig. 8b). LPS-induced phosphorylation of AMPK at Thr172 was decreased by the treatment with NAC (Fig. 8c). Compound C suppressed mitochondrial elongation observed 2–12 hr after the LPS stimulation (Fig. 8d–h), but did not significantly affect production of IL-10 (Supplementary Fig. 1). These results suggest that mitochondrial elongation in microglia after the LPS stimulation is mediated by the production of ROS and activation of AMPK (Fig. 8i).

Figure 8
figure 8

Mitochondrial elongation after a 12 hr stimulation with lipopolysaccharide (LPS) is mediated by reactive oxygen species (ROS) and activated AMP-activated protein kinase (AMPK). Primary microglial cultures were untreated (Cont) or treated with LPS for 2 (2hr) or 12 (12hr) hr with or without drugs including a ROS scavenger (N-acetyl cysteine; NAC) and Compound C (Comp C), and then subjected to Western blotting and immunostaining for TOM20 (a). Western blotting of AMPK phosphorylated at Thr172 (p-AMPK) and total AMPK following LPS stimulation (b). Western blotting of p-AMPK with or without NAC treatment (c, left) and quantification of the western blotting analyses (c, right) are shown. *p < 0.05, **p < 0.01 in t-test (N = 6). Each dot represents each replicate and means (bars) are shown. Representative images (d–g) and the measured lengths (h) of TOM20-immunopositive mitochondrial profiles with or without treatments of NAC (h). The graphical summary of the model is shown (i). N = 1818 (control), 3489 (LPS 2hr), 2238 (LPS 12hr), (LPS 2hr + Comp C) and 3654 (LPS 12hr + Comp C) mitochondria in (h). ****p < 0.0001 in the U-test. Medians (h, bars) with quartile ranges (h, boxes) are shown. Bars: 20 μm.

Discussion

In the present study using SBF-SEM, the mitochondrial morphology of reactive microglia was compared with those of monocyte-derived macrophages and microglia from unaffected brain regions, under demyelinating conditions in vivo. Temporal changes in mitochondrial morphology and associated signaling were also evaluated in primary microglial cultures after the LPS stimulation, using immunocytochemistry and SBF-SEM. Morphological analyses in vivo revealed that mitochondria were longer in MiDM than in MDM at the onset of EAE. On the other hand, the mitochondria of amoeboid microglia in the demyelinated white matter of PLP-overexpressing mice were shorter than those of ramified microglia in the myelinated white matter of wild-type mice. The results of in vitro analyses demonstrated (1) transient mitochondrial shortening after the LPS stimulation via pathways involving Drp1 and ROS, and (2) subsequent elongation along microtubule tracks via pathways involving AMPK (Fig. 8i). Since mitochondrial shortening enhanced the production of ROS in microglia, these results suggest that endogenous signaling pathways in reactive microglia lead to influence mitochondrial dynamics and modulate microglial metabolism and ROS production in neurological disorders.

SBF-SEM revealed the distinct morphology of macrophage populations in detailed 3D ultrastructural analyses of demyelinated mouse CNS tissues and primary microglial cultures. The biphasic alterations in mitochondrial length observed at the ultrastructural level in vitro were consistent with immunohistochemical staining for the markers of the inner and outer mitochondrial membranes, indicating that light and 3D electron microscopic methods are mutually complementary38, 39. In addition, SBF-SEM observations along with pre-embedding immunohistochemistry for extrinsic and intrinsic markers clarified nuclear and mitochondrial morphologies in different MiDM and MDM populations in vivo. The penetration of the immunoreaction product was limited near the surface, but sufficient to identify immunostained cells and their organelles. These approaches may facilitate the identification of ultrastructural features in specific cell populations and tissue compartments under physiological and pathological circumstances.

The 3D morphological in vivo analyses suggested the differential nuclear and mitochondrial morphologies of macrophages in neuroinflammatory and demyelinating diseases. The complexity of nuclear shapes may be relevant to the differential properties of nuclear cytoskeletal elements, including the effects of migratory behaviors, such as extravasation from blood vessels40, 41. Mitochondrial morphology is closely associated with cellular metabolism and functions in neurons and glia42, 43. In peripheral immune cells, metabolic pathways are associated with various immunological functions18, 44. For example, an inflammatory stimulation of macrophages such as that with LPS enhances glycolytic metabolism, inhibits oxidative phosphorylation and increases ROS production from mitochondria44. The generation of ROS has been correlated with mitochondrial fragmentation and the secretion of inflammatory cytokines in cell lines45, 46. MDM have been reported to express higher levels of inflammatory cytokines than MiDM at the onset and peak of EAE5. Differences in organelle morphology between MiDM and MDM support the concept that the behaviors and functions of these two populations of macrophages are distinct in vivo and differentially associated with pathogenesis and potentially with tissue repair in this model of inflammatory demyelination.

Alterations of the mitochondrial dynamics may be related to the differences of microglial phenotypes in the demyelinating disease models. Amoeboid microglia were observed in PLP-overexpressing mice although MiDM in EAE onset bore processes5. Inflammation-associated genes were upregulated in MDM rather than MiDM in EAE5, whereas inflammatory reactions including phospholipase D4 (PLD4), involved in M1 macrophage polarization, was induced in reactive microglia of PLP-tg mice47, 48. However, the limitation of this study is the different brain regions analyzed in different models in order to observe microglial reactions in demyelinated white matter. Further studies on variances of brain regions as well as genetic backgrounds are necessary in order to address if mitochondrial dynamics of reactive microglia is altered in the different demyelination models.

The in vitro analyses demonstrated time-dependent alterations of mitochondrial dynamics and their roles in ROS production in microglia following the inflammatory stimulation of TLR4 with LPS. TLR4 has been implicated in pathophysiology of EAE49, 50. Although involvement of TLR4 is not well understood in the demyelination by PLP overexpression, previous reports suggested that PLD4, involved in M1 macrophage polarization, was induced both in LPS-stimulated primary microglial cultures and in the demyelination model by PLP overexpression47, 48. Thus, it is possible that microglial reactions in PLP-tg and after LPS stimulation at least partly share common signaling pathways. In addition, LPS stimulation of TLR4 has been widely used to investigate inflammatory microglial reactions19, 20, 27. Therefore, the mitochondrial changes and their roles in microglial reactions observed in this study are potentially observed in the other neuroinflammatory circumstances. However, the in vivo environment is difficult to be reproduced in vitro 4, and the phenotypes of reactive microglia in EAE and PLP-tg are unlikely to be uniform. Further studies with different stimulations as well as approaches using in vivo observation and manipulation of mitochondrial dynamics are needed in order to understand the mechanisms and roles of mitochondrial changes in microglia more deeply in vivo.

Morphological changes in mitochondria in vitro are controlled via signaling involving Drp1 in the early phase and ROS-AMPK in the later phase. Multiple mitogen-activated protein kinase (MAPK) pathways lie downstream of the LPS stimulation. It is tempting to speculate that the phosphorylation and activation of Drp1 by specific MAPK signaling pathways may mediate mitochondrial fragmentation, dependent on cellular types and/or metabolic states51, 52. Adding potential complexity, other signaling events may induce mitochondrial fragmentation via the phosphorylation and degradation of Mfn253, 54, rather than the activation of Drp1. The production of ROS has been correlated with mitochondrial fragmentation induced by the activation of Drp145, 55, 56. The mitochondrial fragmentation in LPS-stimulated microglia was not due to apoptotic cell death or cell cycle propagation57, 58, because (1) cellular loss as well as apoptotic morphology was minimal after LPS stimulation and (2) mitochondrial fragmentation was observed in most cells (data not shown). ROS exert various effects; they induce cell damage or promote survival, depending on their concentration and distribution59. The results of the present study suggest that ROS enhanced mitochondrial fragmentation in the early phase, but activated AMPK, which led to mitochondrial elongation in the later phase. AMPK signaling is critical for mitochondrial biogenesis via the induction of peroxisome proliferator-activated receptor gamma coactivator 1-α60. Therefore, these results support the concept that mitochondrial fragmentation and elongation mediated by the dynamic activation of specific pathways contribute to microglial dysfunctions under the conditions of altered CNS homeostasis. Further investigations on the roles of mitochondrial dynamics particularly such as transcription and cytokine productions would be necessary to understand precise roles of mitochondrial dynamics in microglial reactions, since our results suggested that inhibition of mitochondrial fission did not significantly affect LPS-induced production of IL-10. However, our results support the possibility that the restoration of the form and function of microglial mitochondria provides a salient avenue for therapeutic manipulations ameliorating ROS-mediated tissue injuries.

Materials and Methods

Animals, EAE induction and clinical evaluations

All animal experiments were approved by the Institutional Animal Care and Use Committee of University of Yamanashi or Cleveland Clinic, and were performed in accordance with relevant guidelines and regulations. Ccr2 rfp/+::Cx3cr1 gfp/+ mice were generated by crossing Ccr2 rfp/rfp::C57BL/6 mice with Cx3cr1 gfp/gfp::C57BL/6 mice22, 61. PLPtg mice23 were obtained from Riken BRC (Tsukuba, Ibaraki, Japan) and maintained by crossing with DBF-1 mice for >5 generations. Male PLPtg mice and control littermates were used in experiments. DBF-1 and C57BL/6 mice were obtained from Japan SLC (Shizuoka, Japan) or the National Cancer Institute.

EAE was induced in Ccr2 rfp/+::Cx3cr1 gfp/+ mice using myelin-oligodendrocyte-glycoprotein peptide 35–55 (MOG), and all mice were weighed and graded daily for clinical stages, as previously reported5. The onset stage of EAE was defined as the day on which EAE signs appeared.

Primary microglial culture

Primary microglial cultures were prepared as previously reported62, 63. Briefly, the cerebral cortices of newborn C57BL/6 mice were minced and cultured with Dulbecco’s Modified Eagle’s Medium (DMEM) containing 10% fetal bovine serum (FBS) in a 75 cm2 flask for approximately 10–14 days. Microglia were obtained by gently shaking the flask (approximately 100 rpm) for 10 min. The purity of microglia was assessed as >99% by immunostaining for markers (data not shown). Gathered microglia were cultured in DMEM supplemented with 10% FBS and subjected to experiments. LPS and Mdivi-1 were purchased from Sigma-Aldrich Japan (Tokyo, Japan). Compound C (Dorsomorphin) was purchased from Wako (Tokyo, Japan).

Immunocytochemistry and mitochondrial length measurements in cultured microglia

In immunostaining for Iba1, TOM20, VDAC1, COX I and COX Va, microglia were fixed with 4% paraformaldehyde at 4 °C overnight, and then permeabilized in PBS with 0.5% Triton-X for 1hr. In immunostaining for α-tubulin, microglia were subjected to freeze-substitution (FS) followed by quick-freezing (QF), as previously reported64. Briefly, microglial cultures on slide glasses were dipped into isopentane-propane cryogen (−193 °C) and incubated in acetone with dry ice (−80 °C) overnight. The temperature of acetone was gradually increased by incubating the samples at −20 °C, 4 °C, and room temperature for 2 hr each. Samples were incubated with the primary antibody in PBS with 0.1% Triton-X and 5% BSA at 4 °C overnight. Cells were then washed with PBS and incubated with secondary antibodies (Alexa-conjugated) in PBS with 0.1% Triton-X and 5% BSA. The primary antibodies were Iba1 (Wako, 019–19741, 1:2000), TOM20 (Santa Cruz, sc-11415, 1:1000), VDAC1 (Abcam, ab14734, 1:900), COX I (Abcam, ab14705, 1:400), COX Va (Novus Biologicals, NBP1-32550, 1:300), and α-tubulin (Abcam, ab52866, 1:1500).

Mitochondrial lengths were measured with ImageJ following immunocytochemistry for mitochondrial markers. All countable mitochondria in cells were traced by free-hand lines and their lengths were measured. All immunocytochemical experiments for each mitochondrial marker were repeated three times with at least 50 cells in total being measured.

Mitochondrial ROS measurements

ROS generated by mitochondria were measured using MitoSOX red as described previously65. Briefly, cells were incubated with 5 μM MitoSOX for 10 min and washed with medium at 37 °C. Cells were fixed with 4% paraformaldehyde at room temperature for 10 min. Samples were observed by fluorescent microscopy and mean MitoSOX intensity in the cytoplasm was measured using Image J as described previously66.

Western blotting analysis

Microglia in the primary culture were lysed using Laemmli sample buffer (0.5 Tris-HCl [pH 6.8] 12.5 mL, Glycerol 10 mL, 10% SDS 20 mL, 2-mercaptoethanol 50 μL and BPB) with 1% phosphatase inhibitor. Samples were subjected to SDS-PAGE and Western blotting. The primary antibodies used were anti-phospho-Drp1 (Ser616) (Cell Signaling Technology), anti-DLP1 (BD, 611112), anti-phospho-AMPKα (Thr172) (Cell Signaling Technology) and anti-AMPKα (Cell Signaling Technology) and all primary antibodies were diluted 1:1000. The second antibodies used were goat anti-rabbit IgG (H+L), HRP conjugate (Thermo, #31460) and HRP horse anti-mouse IgG antibody (Peroxidase) (Vector Laboratories, PI-2000) and all secondary antibodies were diluted 1:3000. We detected signals using chemiluminescence system.

Serial block-face scanning electron microscopy (SBF-SEM) observations with/without immunohistochemistry

Tissues were removed after mice have been perfusion-fixed using buffered 4% PFA with 1–2.5% glutaraldehyde. Cultured microglia were fixed by immersion in buffered 4% PFA with 0.5% glutaraldehyde. Tissues were immersed in the same fixatives overnight. Brain tissues for immunoelectron microscopy were sliced with a vibratome after fixation, and incubated with primary antibodies against GFP, RFP (Company), and Iba1 (Wako Chemicals). Immunoreaction products were visualized uing the avidin-biotin-horse radish peroxidase complex (ABC) method (Vector) and DAB substrate kit (Pierce, Rockford, IL, USA), and additionally fixed with 4% PFA with 1% glutaraldehyde. In immunostaining for anti-GFP or RFP antibodies, glutaraldehyde was omitted from the fixation step before immunostaining. Samples for SBF-SEM observations were post-fixed with osmium and stained en bloc, as described previously67. Following trimming, samples were imaged with Sigma VP or Merlin (Zeiss) equipped with 3View (Gatan Inc.). The serial images acquired were handled and processed for segmentation with Fiji/ImageJ.

Mitochondrial measurements and nuclear grading in SBF-SEM images

Mitochondria in SBF-SEM images were segmented and reconstructed to 3D images using TrakEM268 and Amira software. Their lengths, volumes and branch numbers were measured or counted from the segmented and tracked mitochondrial profiles in each image with TrakEM2. The characterization of nuclear shapes was conducted using SBF-SEM images, as described previously5. Nuclei were categorized as follows: (1) “Round”, having a round shape and smooth surface with a ratio of length/width ≤ 1.5 with or without small (<half width) indentations; (2) “Elongated”, having an elongated or oval shape with a length/width ratio >1.5 with or without small (<half width) indentations; (3) “Bilobulated”, having two connected lobes with a single intervening large (>half width) indentation; (4) “Irregular”, having complex shape with a corrugated surface, and potentially with multiple and variable sized indentations. Three blinded observers including a research student, research fellow, and neuroscientist scored nuclear morphologies from serial images obtained using SBF-SEM. Observers were trained on the same nuclear examples in each category and practiced using 20 nuclei comprising all shapes before scoring the nuclei. The Kappa test showed good pairwise agreement rates among observers (0.85–0.90) and data from the research fellow were used.

ELISA of IL-10

IL-10 produced by primary microglial culture was measured by Mouse IL-10 ELISA MAX™ Deluxe (BioLegend, Inc.) following manufacture’s protocol. The absorbance at 570 nm of standards and samples were subtracted from the absorbance at 450 nm. Experiment was repeated at least 4 times.

Statistical analysis

Quantifications in the EAE model were performed on 3 individual mice from 3 EAE inductions including 28–35 cells from two separate lesions from each mouse in the assay. Quantifications in PLPtg mice were performed on 3 individual mice from 3 littermates including 6–9 cells from at least 2 different sites of cerebellar white matter. In measurements of the mitochondrial lengths of cultured microglia, experiments were repeated at least 3 times and all data were shown in box graphs which lines were medians and boxes were first-to-third quartile ranges. MitoSOX experiments were performed at least 3 times and representative data were presented in plots. Statistical analyses were performed using Prism (GraphPad Software, La Jolla, CA). Mitochondrial lengths and volumes were measured with ImageJ software, and comparisons were made by the Mann-Whitney U test. Intensity of bands in Western blotting was measured by Image J, and each blot was normalized against control. Comparisons were made by two-tailed Student t tests with Bonferroni corrections. Graphs show medians (bars), quartile ranges (boxes), and 10–90% ranges (whiskers), unless specifically stated.

References

  1. Kreutzberg, G. W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312–318, doi:10.1016/0166-2236(96)10049-7 (1996).

    CAS  Article  PubMed  Google Scholar 

  2. Saijo, K. & Glass, C. K. Microglial cell origin and phenotypes in health and disease. Nat. Rev. Immunol. 11, 775–787, doi:10.1038/nri3086 (2011).

    CAS  Article  PubMed  Google Scholar 

  3. Hanisch, U.-K. & Kettenmann, H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387–1394, doi:10.1038/nn1997 (2007).

    CAS  Article  PubMed  Google Scholar 

  4. Ransohoff, R. M. A polarizing question: do M1 and M2 microglia exist? Nat. Neurosci. 19, 987–991, doi:10.1038/nn.4338 (2016).

    CAS  Article  PubMed  Google Scholar 

  5. Yamasaki, R. et al. Differential roles of microglia and monocytes in the inflamed central nervous system. J. Exp. Med. 211, 1533–1549 (2014).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  6. Ransohoff, R. M. & Perry, V. H. Microglial Physiology: Unique Stimuli, Specialized Responses. Annu. Rev. Immunol. 27, 119–145, doi:10.1146/annurev.immunol.021908.132528 (2009).

    CAS  Article  PubMed  Google Scholar 

  7. Hong, S. et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352, 712–716, doi:10.1126/science.aad8373 (2016).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

  8. Nunnari, J. & Suomalainen, A. Mitochondria: in sickness and in health. Cell 148, 1145–1159 (2012).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  9. Schrepfer, E. & Scorrano, L. Mitofusins, from Mitochondria to Metabolism. Mol. Cell 61, 683–694, doi:10.1016/j.molcel.2016.02.022 (2016).

    CAS  Article  PubMed  Google Scholar 

  10. Westermann, B. Mitochondrial fusion and fission in cell life and death. Nat. Rev. Mol. Cell Biol. 11, 872–884, doi:10.1038/nrm3013 (2010).

    CAS  Article  PubMed  Google Scholar 

  11. Archer, S. L. Mitochondrial dynamics–mitochondrial fission and fusion in human diseases. N. Engl. J. Med. 369, 2236–2251, doi:10.1056/NEJMra1215233 (2013).

    CAS  Article  PubMed  Google Scholar 

  12. Sesaki, H., Adachi, Y., Kageyama, Y., Itoh, K. & Iijima, M. In vivo functions of Drp1: lessons learned from yeast genetics and mouse knockouts. Biochim. Biophys. Acta 1842, 1179–1185 (2014).

    CAS  Article  PubMed  Google Scholar 

  13. Ishihara, T., Kohno, H. & Ishihara, N. Physiological roles of mitochondrial fission in cultured cells and mouse development. Ann. N. Y. Acad. Sci. 1350, 77–81 (2015).

    ADS  CAS  Article  PubMed  Google Scholar 

  14. Kornmann, B. et al. An ER-Mitochondria Tethering Complex Revealed by a Synthetic Biology Screen. Science 325, 477–481, doi:10.1126/science.1175088 (2009).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

  15. Misawa, T. et al. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat. Immunol. 14, 454–460, doi:10.1038/ni.2550 (2013).

    CAS  Article  PubMed  Google Scholar 

  16. Schneeberger, M. et al. Mitofusin 2 in POMC Neurons Connects ER Stress with Leptin Resistance and Energy Imbalance. Cell 155, 172–187, doi:10.1016/j.cell.2013.09.003 (2013).

    CAS  Article  PubMed  Google Scholar 

  17. Shadel, G. S. & Horvath, T. L. Mitochondrial ROS Signaling in Organismal Homeostasis. Cell 163, 560–569, doi:10.1016/j.cell.2015.10.001 (2015).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  18. Weinberg, S. E., Sena, L. A. & Chandel, N. S. Mitochondria in the Regulation of Innate and Adaptive Immunity. Immunity 42, 406–417, doi:10.1016/j.immuni.2015.02.002 (2015).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  19. Lehnardt, S. et al. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J. Neurosci. 22, 2478–2486 (2002).

    CAS  PubMed  Google Scholar 

  20. Papageorgiou, I. E. et al. TLR4-activated microglia require IFN-gamma to induce severe neuronal dysfunction and death in situ. Proc. Natl. Acad. Sci. USA. 113, 212–217 (2016).

    ADS  CAS  Article  PubMed  Google Scholar 

  21. Mizutani, M. et al. The Fractalkine Receptor but Not CCR2 Is Present on Microglia from Embryonic Development throughout Adulthood. J. Immunol. 188, 29–36, doi:10.4049/jimmunol.1100421 (2012).

    CAS  Article  PubMed  Google Scholar 

  22. Saederup, N. et al. Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In Mice. PLoS ONE 5, e13693, doi:10.1371/journal.pone.0013693 (2010).

    ADS  Article  PubMed  PubMed Central  Google Scholar 

  23. Kagawa, T. et al. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13, 427–442, doi:10.1016/0896-6273(94)90358-1 (1994).

    CAS  Article  PubMed  Google Scholar 

  24. Saugier-Veber, P. et al. X–linked spastic paraplegia and Pelizaeus–Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat. Genet. 6, 257–262, doi:10.1038/ng0394-257 (1994).

    CAS  Article  PubMed  Google Scholar 

  25. Readhead, C., Schneider, A., Griffiths, I. & Nave, K.-A. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron 12, 583–595, doi:10.1016/0896-6273(94)90214-3 (1994).

    CAS  Article  PubMed  Google Scholar 

  26. Ip, C. W. et al. Origin of CD11b+ macrophage-like cells in the CNS of PLP-overexpressing mice: Low influx of haematogenous macrophages and unchanged blood-brain-barrier in the optic nerve. Mol. Cell. Neurosci. 38, 489–494, doi:10.1016/j.mcn.2008.04.009 (2008).

    CAS  Article  PubMed  Google Scholar 

  27. Chhor, V. et al. Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav. Immun. 32, 70–85, doi:10.1016/j.bbi.2013.02.005 (2013).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  28. Suen, D.-F., Norris, K. L. & Youle, R. J. Mitochondrial dynamics and apoptosis. Genes Dev. 22, 1577–1590, doi:10.1101/gad.1658508 (2008).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  29. Cassidy-Stone, A. et al. Chemical Inhibition of the Mitochondrial Division Dynamin Reveals Its Role in Bax/Bak-Dependent Mitochondrial Outer Membrane Permeabilization. Dev. Cell 14, 193–204, doi:10.1016/j.devcel.2007.11.019 (2008).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  30. Sharp, W. W. et al. Dynamin-related protein 1 (Drp1)-mediated diastolic dysfunction in myocardial ischemia-reperfusion injury: therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission. FASEB J. 28, 316–326, doi:10.1096/fj.12-226225 (2014).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  31. Bettelli, E. et al. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161, 3299–306 (1998).

    CAS  PubMed  Google Scholar 

  32. Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M. & O’Garra, A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147, 3815–22 (1991).

    CAS  PubMed  Google Scholar 

  33. Wang, B. et al. Microtubule acetylation amplifies p38 kinase signalling and anti-inflammatory IL-10 production. Nat. Commun. 5, 3479, doi:10.1038/ncomms4479 (2014).

    PubMed  PubMed Central  Google Scholar 

  34. Dugan, L. L. et al. AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function. J. Clin. Invest. 123, 4888–4899, doi:10.1172/JCI66218 (2013).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  35. Reznick, R. M. & Shulman, G. I. The role of AMP-activated protein kinase in mitochondrial biogenesis. J. Physiol. 574, 33–39, doi:10.1113/jphysiol.2006.109512 (2006).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  36. Zong, H. et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl. Acad. Sci. USA. 99, 15983–15987, doi:10.1073/pnas.252625599 (2002).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

  37. Zhou, G. et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167–1174, doi:10.1172/JCI200113505 (2001).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  38. Nikic, I. et al. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat. Med. 17, 495–499 (2011).

    CAS  Article  PubMed  Google Scholar 

  39. Ohno, N. et al. Mitochondrial immobilization mediated by syntaphilin facilitates survival of demyelinated axons. Proc. Natl. Acad. Sci. USA 111, 9953–9958 (2014).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

  40. Jevtić, P., Edens, L. J., Vuković, L. D. & Levy, D. L. Sizing and shaping the nucleus: mechanisms and significance. Curr. Opin. Cell Biol. 28, 16–27, doi:10.1016/j.ceb.2014.01.003 (2014).

    Article  PubMed  Google Scholar 

  41. Rowat, A. C. et al. Nuclear Envelope Composition Determines the Ability of Neutrophil-type Cells to Passage through Micron-scale Constrictions. J. Biol. Chem. 288, 8610–8618, doi:10.1074/jbc.M112.441535 (2013).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  42. Khacho, M. et al. Acidosis overrides oxygen deprivation to maintain mitochondrial function and cell survival. Nat. Commun. 5, 3550, doi:10.1038/ncomms4550 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  43. Motori, E. et al. Inflammation-Induced Alteration of Astrocyte Mitochondrial Dynamics Requires Autophagy for Mitochondrial Network Maintenance. Cell Metab. 18, 844–859, doi:10.1016/j.cmet.2013.11.005 (2013).

    CAS  Article  PubMed  Google Scholar 

  44. Galván-Peña, S. & O’Neill, L. A. J. Metabolic reprograming in macrophage polarization. Front. Immunol 5, 420, doi:10.3389/fimmu.2014.00420 (2014).

    PubMed  PubMed Central  Google Scholar 

  45. Park, J. et al. Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells. J. Neurochem. 127, 221–232, doi:10.1111/jnc.12361 (2013).

    CAS  Article  PubMed  Google Scholar 

  46. Park, J. et al. Mitochondrial ROS govern the LPS-induced pro-inflammatory response in microglia cells by regulating MAPK and NF-κB pathways. Neurosci. Lett. 584, 191–196, doi:10.1016/j.neulet.2014.10.016 (2015).

    CAS  Article  PubMed  Google Scholar 

  47. Otani, Y. et al. PLD4 is involved in phagocytosis of microglia: expression and localization changes of PLD4 are correlated with activation state of microglia. PLoS One. 6, e27544, doi:10.1371/journal.pone.0027544 (2011).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

  48. Gao, L. et al. PLD4 promotes M1 macrophages to perform antitumor effects in colon cancer cells. Oncol Rep. 37, 408–416, doi:10.3892/or.2016.5216 (2017).

    PubMed  Google Scholar 

  49. Kerfoot, S. M. et al. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J Immunol. 173, 7070–7077 (2004).

    CAS  Article  PubMed  Google Scholar 

  50. Marta, M. et al. Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis. Eur J Immunol. 38, 565–75, doi:10.1002/eji.200737187 (2008).

    CAS  Article  PubMed  Google Scholar 

  51. Kashatus, J. A. et al. Erk2 Phosphorylation of Drp1 Promotes Mitochondrial Fission and MAPK-Driven Tumor Growth. Mol. Cell 57, 537–551, doi:10.1016/j.molcel.2015.01.002 (2015).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  52. Serasinghe, M. N. et al. Mitochondrial Division Is Requisite to RAS-Induced Transformation and Targeted by Oncogenic MAPK Pathway Inhibitors. Mol. Cell 57, 521–536, doi:10.1016/j.molcel.2015.01.003 (2015).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  53. Leboucher, G. P. et al. Stress-Induced Phosphorylation and Proteasomal Degradation of Mitofusin 2 Facilitates Mitochondrial Fragmentation and Apoptosis. Mol. Cell 47, 547–557, doi:10.1016/j.molcel.2012.05.041 (2012).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  54. Senyilmaz, D. et al. Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature 525, 124–128, doi: 10.1038/nature14601 [pii]\r (2015).

  55. Qi, X., Qvit, N., Su, Y.-C. & Mochly-Rosen, D. A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J. Cell Sci. 126, 789–802, doi:10.1242/jcs.114439 (2013).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  56. Wu, S., Zhou, F., Zhang, Z. & Xing, D. Mitochondrial oxidative stress causes mitochondrial fragmentation via differential modulation of mitochondrial fission-fusion proteins. FEBS J. 278, 941–954, doi:10.1111/j.1742-4658.2011.08010.x (2011).

    CAS  Article  PubMed  Google Scholar 

  57. Frank, S. et al. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev. Cell 1, 515–525 (2001).

    CAS  Article  PubMed  Google Scholar 

  58. Taguchi, N., Ishihara, N., Jofuku, A., Oka, T. & Mihara, K. Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J. Biol. Chem. 282, 11521–11529 (2007).

    CAS  Article  PubMed  Google Scholar 

  59. Sanz, A. Mitochondrial reactive oxygen species: Do they extend or shorten animal lifespan? Biochim. Biophys. Acta 1857, 1116–1126 (2016).

    CAS  Article  PubMed  Google Scholar 

  60. Cantó, C. & Auwerx, J. PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr. Opin. Lipidol. 20, 98–105, doi:10.1097/MOL.0b013e328328d0a4 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  61. Jung, S. et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20, 4106–4114, doi:10.1128/MCB.20.11.4106-4114.2000.Updated (2000).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  62. Nakajima, K. et al. Identification of Elastase as a Secretory Protease from Cultured Rat Microglia. J. Neurochem. 58, 1401–1408, doi:10.1111/j.1471-4159.1992.tb11356.x (1992).

    CAS  Article  PubMed  Google Scholar 

  63. Shinozaki, Y. et al. Microglia trigger astrocyte-mediated neuroprotection via purinergic gliotransmission. Sci. Rep. 4, 4329 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  64. Lei, T. et al. Bioimaging of fluorescence-labeled mitochondria in subcutaneously grafted murine melanoma cells by the “in vivo cryotechnique”. J. Histochem. Cytochem. 62, 251–264 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  65. Marella, M., Seo, B. B., Matsuno-Yagi, A. & Yagi, T. Mechanism of Cell Death Caused by Complex I Defects in a Rat Dopaminergic Cell Line. J. Biol. Chem. 282, 24146–24156, doi:10.1074/jbc.M701819200 (2007).

    CAS  Article  PubMed  Google Scholar 

  66. Robinson, K. M. et al. Selective fluorescent imaging of superoxide in vivo using ethidium-based probes. Proc. Natl. Acad. Sci. USA 103, 15038–15043, doi:10.1073/pnas.0601945103 (2006).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

  67. Ohno, N. et al. Myelination and axonal electrical activity modulate the distribution and motility of mitochondria at CNS nodes of Ranvier. J. Neurosci. 31, 7249–7258 (2011).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  68. Cardona, A. et al. TrakEM2 software for neural circuit reconstruction. PLoS ONE 7, e38011 (2012).

    ADS  CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work is partly supported by JSPS KAKENHI Grant Number JP16H06280, Cooperative Research Program of “Network Joint Research Center for Materials and Devices”, the US National Institutes of Health (R01 NS32151 to R.M.R.) and research grant from Novartis Pharma, Cooperative Study Programs of National Institute for Physiological Sciences (to N.O.).

Author information

Authors and Affiliations

Authors

Contributions

N.O. designed the study, M.K. and N.O. wrote the original draft; M.K., B.W., H.B.N., T.Q.T., R.Y., H.L., A.M.R., M.M.Z., Y.Sh., Y.Sa., S.S., T.S. and N.O. performed the investigation and analyses of data; K.I., S.K. and R.M.R. contributed to data collection and interpretation; all authors have critically reviewed and approved the manuscript.

Corresponding author

Correspondence to Nobuhiko Ohno.

Ethics declarations

Competing Interests

The authors declare that they have no competing interests.

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Katoh, M., Wu, B., Nguyen, H. et al. Polymorphic regulation of mitochondrial fission and fusion modifies phenotypes of microglia in neuroinflammation. Sci Rep 7, 4942 (2017). https://doi.org/10.1038/s41598-017-05232-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41598-017-05232-0

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing